Literature DB >> 19924363

Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan.

I-Chia Chien1, Shin-Huey Bih, Ching-Heng Lin, Yiing-Jenq Chou, Wen-Guang Lee, Cheng-Hua Lee, Pesus Chou.   

Abstract

PURPOSE: We used the population-based National Health Insurance database to investigate correlates and psychiatric disorders associated with psychotropic drug use in Taiwan.
METHODS: The National Health Research Institute provided a database of 200,000 random subjects for study. We obtained a random sample of 145,304 subjects aged 18 years or older in 2004. Study subjects who had made at least two psychotropic drug prescriptions during this year were identified. We detected factors associated with psychotropic drug use. In addition, we examined the prevalence of antipsychotic, antidepressant, mood stabilizer, sedative-hypnotic-anxiolytic (SHA) agent, and any psychotropic drug use according to psychiatric disorders.
RESULTS: Higher prevalence of any psychotropic drug use was found in the 25-44, 45-64, and 65 or older age groups, females, aborigine, with a lower premium, with disability, and among those who lived in central region, suburban or rural area. Among those subjects with any major psychiatric disorders, the prevalence of antipsychotic, antidepressant, mood stabilizer, SHA agent, and any psychotropic drug use were 59.3, 49.7, 17.9, 78.6, and 92.0%, respectively. Among those subjects with any minor psychiatric disorders, the prevalence of antipsychotic, antidepressant, mood stabilizer, SHA agent and any psychotropic drug use were 17.5, 41.8, 4.0, 85.5, and 89.4%, respectively.
CONCLUSIONS: Thus, those subjects with any psychiatric disorders had a high percentage of any psychotropic drug use in National Health Insurance program in Taiwan. Future studies should focus on the outcome evaluation and correlates associated with individual psychotropic use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924363     DOI: 10.1007/s00127-009-0169-3

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  30 in total

1.  Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996-2001.

Authors:  I-Chia Chien; Yiing-Jenq Chou; Ching-Heng Lin; Shin-Huey Bih; Pesus Chou; Hong-Jen Chang
Journal:  Psychiatry Clin Neurosci       Date:  2004-12       Impact factor: 5.188

2.  U.S. national trends in the use of antipsychotics during office visits, 1998-2002.

Authors:  Rajender R Aparasu; Vinod Bhatara; Sanjay Gupta
Journal:  Ann Clin Psychiatry       Date:  2005 Jul-Sep       Impact factor: 1.567

3.  The prevalence and incidence of treated major depressive disorder among National Health Insurance enrollees in Taiwan, 1996 to 2003.

Authors:  I-Chia Chien; Chien-Cheng Kuo; Shin-Huey Bih; Yiing-Jenq Chou; Ching-Heng Lin; Cheng-Hua Lee; Pesus Chou
Journal:  Can J Psychiatry       Date:  2007-01       Impact factor: 4.356

4.  Off-label use of antipsychotic drugs.

Authors:  E Weiss; M Hummer; D Koller; H Ulmer; W W Fleischhacker
Journal:  J Clin Psychopharmacol       Date:  2000-12       Impact factor: 3.153

5.  Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule.

Authors:  H G Hwu; E K Yeh; L Y Chang
Journal:  Acta Psychiatr Scand       Date:  1989-02       Impact factor: 6.392

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Mental health-related drug utilization among older adults: prevalence, trends, and costs.

Authors:  Muhammad Mamdani; Mark Rapoport; Kenneth I Shulman; Nathan Herrmann; Paula A Rochon
Journal:  Am J Geriatr Psychiatry       Date:  2005-10       Impact factor: 4.105

8.  Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan.

Authors:  I-Chia Chien; Yiing-Jenq Chou; Ching-Heng Lin; Shin-Huey Bih; Pesus Chou
Journal:  Psychiatr Serv       Date:  2004-06       Impact factor: 3.084

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002.

Authors:  Thomas Delate; Alan J Gelenberg; Valarie A Simmons; Brenda R Motheral
Journal:  Psychiatr Serv       Date:  2004-04       Impact factor: 3.084

View more
  5 in total

1.  Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan.

Authors:  Yuan-Chang Hsu; I-Chia Chien; Happy Kuy-Lok Tan; Ching-Heng Lin; Shu-Wen Cheng; Yiing-Jenq Chou; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-08       Impact factor: 4.328

2.  Predictors of prescribed medication use for depression, anxiety, stress, and sleep problems in mid-aged Australian women.

Authors:  Margot J Schofield; Asaduzzaman Khan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-07       Impact factor: 4.328

3.  Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study.

Authors:  Shih-Chun Hsing; Yo-Ting Jin; Nian-Sheng Tzeng; Chi-Hsiang Chung; Tien-Yu Chen; Hsin-An Chang; Yu-Chen Kao; Wu-Chien Chien
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-22       Impact factor: 2.570

4.  Psychotropic Drug Use in São Paulo, Brazil--An Epidemiological Survey.

Authors:  Maria Ines Quintana; Sergio Baxter Andreoli; Marcela Poctich Peluffo; Wagner Silva Ribeiro; Marcelo M Feijo; Rodrigo Affonseca Bressan; Evandro S F Coutinho; Jair de Jesus Mari
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

5.  Prevalence and predictors of psychotropic medication use: results from the Northern Ireland Study of Health and Stress.

Authors:  T Benson; S O'Neill; S Murphy; F Ferry; B Bunting
Journal:  Epidemiol Psychiatr Sci       Date:  2014-09-15       Impact factor: 6.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.